Crossmark

Neuromodulation by nanozymes and ultrasound during Alzheimer’s disease management

Crossref DOI link: https://doi.org/10.1186/s12951-024-02406-7

Published Online: 2024-03-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Karthika, Viswanathan

Badrinathan Sridharan,

Nam, Ji Won

Kim, Daehun

Gyun Lim, Hae
Funding

Funding for this research was provided by:

Samsung Research Funding & Incubation Center (SRFC-IT2202-02)

Samsung Research Funding & Incubation Center (SRFC-IT2202-02)

Samsung Research Funding & Incubation Center (SRFC-IT2202-02)

Samsung Research Funding & Incubation Center (SRFC-IT2202-02)

Samsung Research Funding & Incubation Center (SRFC-IT2202-02)

Regional Innovation Leading Research Center (2022R1A5A8023404)

Regional Innovation Leading Research Center (2022R1A5A8023404)

Regional Innovation Leading Research Center (2022R1A5A8023404)

Regional Innovation Leading Research Center (2022R1A5A8023404)

Regional Innovation Leading Research Center (2022R1A5A8023404)

BrainLink program funded by the Ministry of Science and ICT through the National Research Foundation of Korea. (RS-2023-00236798)

BrainLink program funded by the Ministry of Science and ICT through the National Research Foundation of Korea. (RS-2023-00236798)

BrainLink program funded by the Ministry of Science and ICT through the National Research Foundation of Korea. (RS-2023-00236798)

BrainLink program funded by the Ministry of Science and ICT through the National Research Foundation of Korea. (RS-2023-00236798)

BrainLink program funded by the Ministry of Science and ICT through the National Research Foundation of Korea. (RS-2023-00236798)
License Information

Text and Data Mining valid from 2024-03-30

Version of Record valid from 2024-03-30
More Information

Article History

Received: 27 September 2023

Accepted: 18 March 2024

First Online: 30 March 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below